NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC…
Reason Chemical contamination; presence of lead and lithium above specification
54 FDA recalls mention Alpha. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Alpha.
Reason Chemical contamination; presence of lead and lithium above specification
Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Reason Lack of Assurance of Sterility
Reason Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.
Reason Subpotent drug
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Reason CGMP Deviations
Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Reason Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Reason Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Reason Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Reason Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
Reason Lack of assurance of sterility.
Reason Lack of Assurance of Sterility
Reason Marketed Without an Approved NDA/ANDA: FDA analysis determined the presence of tadalafil
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Reason Marketed without an Approved NDA/ANDA: Product marketed with drug claims.
Reason GMP Deviations
Reason Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
Reason Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.